{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":24,"sponsored":0,"items":[{"id":"n_6vd2fiubnm3naa3tfjwq","seq":1473690,"kind":"article","title":"Eli Lilly (LLY) and AbbVie (ABBV) Are Expanding Their Pipelines. Their Valuations Tell Two Different Stories","url":"https://www.insidermonkey.com/news/eli-lilly-lly-and-abbvie-abbv-are-expanding-their-pipelines-their-valuations-tell-two-different-stories-1847639","published":"2026-10-03T04:19:17Z","seen":"2026-10-03T04:19:17Z","lang":"en","source":{"id":"insidermonkey.com","name":"insidermonkey.com","domain":"insidermonkey.com"},"via":"gdelt-gkg-english","topics":["economy","health","business"],"authors":["Faheem Tahir"],"entities":[{"id":"Q2984214","name":"Eli Lilly","type":"org"},{"id":"Q14662364","name":"AbbVie","type":"org"}],"story":"st_6vd2fiubnm3naa3tfjwq","category":"economy-business","category_p":0.93,"sentiment":"neutral","tone":0.08,"political":0.01},{"id":"n_lebxixt2ik5ywqaghl5q","seq":1418119,"kind":"article","title":"Federal Circuit Denies En Banc Rehearing In Teva v. Eli Lilly, Preserving Precedent For Method-of-Treatment Patent Claims","url":"https://www.mondaq.com/unitedstates/patent/1849682/federal-circuit-denies-en-banc-rehearing-in-teva-v-eli-lilly-preserving-precedent-for-method-of-treatment-patent-claims","published":"2026-10-02T19:15:00Z","seen":"2026-10-02T19:46:33Z","lang":"en","source":{"id":"mondaq.com","name":"mondaq.com","domain":"mondaq.com","outlet":{"wikidata":"Q96393761","name":"Mondaq","type":"website","country":"US","designations":["website"]}},"via":"gdelt-gkg-english","topics":["economy","science","politics"],"entities":[{"id":"Q1763845","name":"United States Court of Appeals for the Federal Circuit","type":"org"},{"id":"Q2868194","name":"World Esperantist Vegetarian Association","type":"org"},{"id":"Q2984214","name":"Eli Lilly","type":"org"}],"story":"st_lebxixt2ik5ywqaghl5q","category":"politics","category_p":0.29,"sentiment":"neutral","tone":-0.27,"political":0.29},{"id":"n_unipndpgxqtsu4nx6hza","seq":1291585,"kind":"article","title":"Katwijk approves permits for $3 billion Eli Lilly pharmaceutical plant","url":"https://nltimes.nl/2026/10/02/katwijk-approves-permits-3-billion-eli-lilly-pharmaceutical-plant","summary":"The American company Eli Lilly has received the green light to build a $3 billion pharmaceutical plant in Katwijk. The municipal council has approved its permit application.","published":"2026-10-02T07:49:34Z","seen":"2026-10-02T07:49:34Z","lang":"en","country":"NL","source":{"id":"kite-nltimes-nl-a96e15","name":"nltimes.nl","domain":"nltimes.nl","outlet":{"wikidata":"Q140447891","name":"NL Times","type":"website","country":"NL","designations":["enterprise","news website"]}},"via":"kite-nltimes-nl-a96e15","authors":["92122"],"entities":[{"id":"Q208764","name":"Katwijk","type":"place"},{"id":"Q2984214","name":"Eli Lilly","type":"org"}],"mentions":2,"story":"st_c2mwofk4h7uhqxczrj7q","category":"economy-business","category_p":0.72,"sentiment":"positive","tone":0.29,"political":0.25},{"id":"n_safw62qws3qjlqqwbusq","seq":1270096,"kind":"article","title":"Eli Lilly's obesity pill could reach India in 2027; CEO says launch awaits approval","url":"https://www.moneycontrol.com/news/business/eli-lilly-s-obesity-pill-could-reach-india-in-2027-ceo-says-launch-awaits-approval-14043285.html","published":"2026-10-02T05:22:43Z","seen":"2026-10-02T05:22:43Z","lang":"en","source":{"id":"moneycontrol.com","name":"moneycontrol.com","domain":"moneycontrol.com","outlet":{"wikidata":"Q19573046","name":"Moneycontrol","type":"website","country":"IN","designations":["news website"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"entities":[{"id":"Q2984214","name":"Eli Lilly","type":"org"}],"story":"st_safw62qws3qjlqqwbusq","category":"economy-business","category_p":0.62,"category2":"health","sentiment":"neutral","tone":0.24,"political":0.05},{"id":"n_ie3x7lo2iyt7xjthyh6a","seq":1232715,"kind":"article","title":"Katwijk stemt in met komst miljardenfabriek Amerikaanse farmaceut","title_en":"Katwijk agrees to the arrival of a billion-dollar factory of American pharmaceutical company","url":"https://www.tubantia.nl/binnenland/katwijk-stemt-in-met-komst-miljardenfabriek-amerikaanse-farmaceut~af2f71b8f","summary":"Het Amerikaanse bedrijf Eli Lilly kan voor 3 miljard dollar een medicijnfabriek gaan bouwen in Katwijk. De gemeenteraad heeft ingestemd met de vergunningaanvraag.","published":"2026-10-01T22:53:00Z","seen":"2026-10-01T23:08:45Z","lang":"nl","country":"NL","source":{"id":"kite-tubantia-nl-412df2","name":"tubantia.nl","domain":"tubantia.nl","outlet":{"wikidata":"Q1180408","name":"De Twentsche Courant Tubantia","type":"newspaper","designations":["newspaper"]}},"via":"kite-tubantia-nl-412df2","authors":["author"],"entities":[{"id":"Q208764","name":"Katwijk","type":"place"},{"id":"Q2984214","name":"Eli Lilly","type":"org"}],"image":"https://images.tubantia.nl/YzdmMWFkNDAxZTMxMTg4ZTViYTcvZGlvLzI3ODQyMTY5NS9maXQtd2lkdGgvNDAw/2026-10-01-14-58-54-katwijk-dronefoto-van-de-beoogde-locatie-waar-eli-lilly-een-medicijnenfabriek-wil-bouwen-de-amerikaanse-farmaceut-wil-in-katwijk-geneesmiddelen-maken-op-het-gebied-van-diabetes-obesitas-hart-en-vaataandoeningen-oncologie-immunologie-en-neuroscience-ramon-van-flymen-anp","mentions":2,"story":"st_c2mwofk4h7uhqxczrj7q","category":"economy-business","category_p":0.85,"sentiment":"positive","tone":0.55,"political":0.48},{"id":"n_c2mwofk4h7uhqxczrj7q","seq":1232691,"kind":"article","title":"Katwijk stemt in met komst miljardenfabriek Amerikaanse farmaceut Eli Lilly","title_en":"Katwijk agrees to the arrival of a billion-dollar factory of American pharmaceutical company Eli Lilly","url":"https://nos.nl/l/2633354","summary":"Het Amerikaanse farmaciebedrijf Eli Lilly kan voor 3 miljard dollar een medicijnfabriek gaan bouwen in Katwijk. De gemeenteraad heeft ingestemd met de vergunningaanvraag. Eli Lilly, een van de grootste farmaceuten ter wereld, wil vlak bij het Valkenburgse Meer in Katwijk diabetes- en afslankpillen gaan produceren. In de fabriek komen zo'n 500 mensen te werken, meldt Omroep West . Eerder op donderdagavond werd al bekend dat er in Katwijk geen referendum gaat komen over de…","published":"2026-10-01T22:50:42Z","seen":"2026-10-01T23:08:28Z","lang":"nl","country":"NL","source":{"id":"nos","name":"NOS Nieuws","domain":"nos.nl","outlet":{"wikidata":"Q1515393","name":"Nederlandse Omroep Stichting","type":"broadcaster","country":"NL","designations":["broadcaster","production company"]}},"via":"nos","entities":[{"id":"Q208764","name":"Katwijk","type":"place"},{"id":"Q2984214","name":"Eli Lilly","type":"org"}],"image":"https://images.cdn.nos.nl/5/B/X/D/R/8/EKmqE8qHpCkdBcqoVddcEhJa4WESe9PJ7ggNDB5/8x212x3984x2241-1024x576.webp","story":"st_c2mwofk4h7uhqxczrj7q","category":"economy-business","category_p":0.78,"sentiment":"positive","tone":0.54,"political":0.33},{"id":"n_pyaujrfnk6kglv7zmg3q","seq":1054309,"kind":"article","title":"Thin Is Back: Eli Lilly, Vogue and Weight-Loss Marketing","url":"https://openthemagazine.com/branding-marketing-and-advertising/thin-is-back-this-time-it-has-a-sponsor","published":"2026-10-01T04:56:38Z","seen":"2026-10-01T04:56:38Z","lang":"en","source":{"id":"openthemagazine.com","name":"openthemagazine.com","domain":"openthemagazine.com","outlet":{"wikidata":"Q7072818","name":"OPEN","type":"magazine","designations":["magazine"]}},"via":"gdelt-gkg-english","topics":["economy","business","health"],"authors":["Ashita Aggarwal"],"entities":[{"id":"Q2984214","name":"Eli Lilly","type":"org"},{"id":"Q154008","name":"Vogue","type":"org"}],"story":"st_pyaujrfnk6kglv7zmg3q","category":"arts-culture-entertainment","category_p":0.36,"category2":"economy-business","sentiment":"neutral","tone":0.37,"political":0.02},{"id":"n_5pqqe4popeozge3ve3dq","seq":1000890,"kind":"article","title":"Eli Lilly Diabetes Drug Spurs Record Weight Loss in Trials","url":"https://www.newser.com/story/397336/eli-lilly-diabetes-drug-spurs-record-weight-loss-in-trials.html","published":"2026-09-30T21:00:00Z","seen":"2026-09-30T21:02:14Z","lang":"en","source":{"id":"newser.com","name":"newser.com","domain":"newser.com","outlet":{"wikidata":"Q7019626","name":"Newser","type":"other","country":"US","designations":["news aggregator"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Jenn Gidman"],"entities":[{"id":"Q2984214","name":"Eli Lilly","type":"org"}],"story":"st_pqzjedvwflzdwkl2amdq","category":"health","category_p":0.62,"sentiment":"negative","tone":-0.67,"political":0.03},{"id":"n_lqm7udfllloau523cpaa","seq":937326,"kind":"article","title":"Could This Company Challenge Eli Lilly and Novo Nordisk in the Weight Loss Market?","url":"https://www.aol.com/articles/could-company-challenge-eli-lilly-144401000.html","published":"2026-09-30T14:44:00Z","seen":"2026-09-30T15:23:34Z","lang":"en","source":{"id":"aol.com","name":"aol.com","domain":"aol.com","outlet":{"wikidata":"Q27585","name":"AOL","type":"website","country":"US","designations":["business","company","enterprise","media company","online service provider","search engine","web portal"]}},"via":"gdelt-gkg-english","topics":["economy","health","business"],"authors":["AOL"],"entities":[{"id":"Q2984214","name":"Eli Lilly","type":"org"},{"id":"Q818846","name":"Novo","type":"org"}],"story":"st_et23qkz3l4wf7sbdhxuq","category":"economy-business","category_p":0.82,"sentiment":"neutral","tone":0.11,"political":0.0},{"id":"n_33kvalxmydfw25gui2ca","seq":849710,"kind":"article","title":"Patrik Jonsson (Eli Lilly): «Scienze della vita e terapie innovative. L’Italia investa sulla prevenzione»","title_en":"Patrik Jonsson (Eli Lilly): “Life sciences and innovative therapies. Italy should invest in prevention”","url":"https://www.ilsole24ore.com/art/patrik-jonsson-eli-lilly-scienze-vita-e-terapie-innovative-l-italia-investa-prevenzione-AJVc2MTB","summary":"L’executive vice presidente di Eli Lilly e presidente di Lilly International «Usa e Cina corrono, mentre l’Europa rischia di perdere competitività. Sesto Fiorentino sito modello»","published":"2026-09-30T07:02:01Z","seen":"2026-09-30T07:50:59Z","lang":"it","source":{"id":"kite-ilsole24ore-com-b69842","name":"ilsole24ore.com","domain":"ilsole24ore.com","outlet":{"wikidata":"Q1658262","name":"Il Sole 24 Ore","type":"newspaper","country":"IT","designations":["daily newspaper","large publisher"]}},"via":"kite-ilsole24ore-com-b69842","topics":["economy","economia"],"authors":["di Francesca Cerati"],"entities":[{"id":"Q2984214","name":"Eli Lilly","type":"org"}],"image":"https://i2.res.24o.it/images2010/S24/Documenti/2026/09/30/Immagini/Ritagli/lilly-U37170000607HcW-1440x752@IlSole24Ore-Web.jpg","story":"st_33kvalxmydfw25gui2ca","category":"health","category_p":0.7,"sentiment":"neutral","tone":0.15,"political":0.08},{"id":"n_mfabktfnqeoxs3b2nnwq","seq":801204,"kind":"article","title":"Opinion: Eli Lilly Stock Is a No-Brainer Pick to Buy on the Dip","url":"https://www.aol.com/articles/opinion-eli-lilly-stock-no-012000000.html","published":"2026-09-30T01:20:00Z","seen":"2026-09-30T01:46:20Z","lang":"en","source":{"id":"aol.com","name":"aol.com","domain":"aol.com","outlet":{"wikidata":"Q27585","name":"AOL","type":"website","country":"US","designations":["business","company","enterprise","media company","online service provider","search engine","web portal"]}},"via":"gdelt-gkg-english","topics":["economy","business","health"],"authors":["AOL"],"entities":[{"id":"Q2984214","name":"Eli Lilly","type":"org"}],"story":"st_mykj3pl5yhsccaldii2q","category":"economy-business","category_p":0.74,"sentiment":"positive","tone":0.13,"political":0.01},{"id":"n_j3vr6guswof25iz7onxq","seq":801436,"kind":"article","title":"Eli Lilly Might Be the Next Stock I Buy","url":"https://www.fool.com/investing/2026/09/29/eli-lilly-might-be-the-next-stock","published":"2026-09-30T01:10:00Z","seen":"2026-09-30T01:46:20Z","lang":"en","source":{"id":"fool.com","name":"fool.com","domain":"fool.com","outlet":{"wikidata":"Q7752442","name":"The Motley Fool","type":"other","country":"US","designations":["dot-com company"]}},"via":"gdelt-gkg-english","topics":["business","education","economy"],"authors":["Parkev Tatevosian","CFA"],"entities":[{"id":"Q2984214","name":"Eli Lilly","type":"org"}],"story":"st_j3vr6guswof25iz7onxq","category":"economy-business","category_p":0.66,"sentiment":"neutral","tone":0.34,"political":0.01},{"id":"n_qq62awx25p7zo52ahqla","seq":794053,"kind":"article","title":"Bristol Myers Squibb vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026?","url":"https://www.fool.com/coverage/better-buy/2026/09/29/bristol-myers-squibb-vs-eli-lilly-and-which-healthcare-stock-is-a-better-buy-in-2026","published":"2026-09-29T22:22:00Z","seen":"2026-09-30T00:28:24Z","lang":"en","source":{"id":"fool.com","name":"fool.com","domain":"fool.com","outlet":{"wikidata":"Q7752442","name":"The Motley Fool","type":"other","country":"US","designations":["dot-com company"]}},"via":"gdelt-gkg-english","topics":["economy","business","health","politics"],"authors":["Brendan Coffey"],"entities":[{"id":"Q2984214","name":"Eli Lilly","type":"org"}],"story":"st_u4ya6dccmqilmiqwjh2q","category":"economy-business","category_p":0.54,"category2":"health","sentiment":"neutral","tone":0.07,"political":0.02},{"id":"n_pqzjedvwflzdwkl2amdq","seq":778830,"kind":"article","title":"Eli Lilly's Experimental Weight-Loss Drug Shows Promising Results","url":"https://time.com/article/2026/09/29/eli-lilly-triple-targeting-experimental-weight-loss-drug-promising-results","published":"2026-09-29T22:00:00Z","seen":"2026-09-29T22:34:08Z","lang":"en","source":{"id":"time.com","name":"time.com","domain":"time.com","outlet":{"wikidata":"Q43297","name":"Time","type":"magazine","country":"US","designations":["magazine","news magazine","online magazine","website"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Alice Park"],"entities":[{"id":"Q2984214","name":"Eli Lilly","type":"org"}],"story":"st_pqzjedvwflzdwkl2amdq","category":"health","category_p":0.65,"sentiment":"positive","tone":0.14,"political":0.01},{"id":"n_vgohyvmnucb3mnrgs6ja","seq":778383,"kind":"article","title":"Eli Lilly Stock Barely Moved Following Viking Therapeutics' Impressive Clinical Results. Here's Why.","url":"https://www.aol.com/articles/eli-lilly-stock-barely-moved-215000000.html","published":"2026-09-29T21:50:00Z","seen":"2026-09-29T22:33:16Z","lang":"en","source":{"id":"aol.com","name":"aol.com","domain":"aol.com","outlet":{"wikidata":"Q27585","name":"AOL","type":"website","country":"US","designations":["business","company","enterprise","media company","online service provider","search engine","web portal"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["AOL"],"entities":[{"id":"Q2984214","name":"Eli Lilly","type":"org"},{"id":"Q30269384","name":"Viking Therapeutics","type":"org"}],"story":"st_3kyht6k767z6zhxpatwq","category":"economy-business","category_p":0.49,"category2":"health","sentiment":"positive","tone":-0.03,"political":0.01},{"id":"n_257jsgaq7ei4nuzxd4ia","seq":759503,"kind":"article","title":"Eli Lilly Upgraded, Intel Downgraded: Updated Rankings on Top Blue-Chip Stocks","url":"https://investorplace.com/market360/2026/09/20260928-blue-chip-upgrades-downgrades","published":"2026-09-29T20:11:01Z","seen":"2026-09-29T20:11:01Z","lang":"en","source":{"id":"investorplace.com","name":"investorplace.com","domain":"investorplace.com"},"via":"gdelt-gkg-english","topics":["health","economy","technology","business"],"authors":["Louis Navellier"],"entities":[{"id":"Q2984214","name":"Eli Lilly","type":"org"},{"id":"Q248","name":"Intel","type":"org"}],"story":"st_257jsgaq7ei4nuzxd4ia","category":"economy-business","category_p":0.74,"category2":"science-technology","sentiment":"neutral","tone":0.4,"political":0.01},{"id":"n_4beqmtf4juhxvtlumsia","seq":749339,"kind":"article","title":"Prediction: Eli Lilly's Next Growth Wave Could Surprise Investors","url":"https://www.aol.com/articles/prediction-eli-lilly-next-growth-180018000.html","published":"2026-09-29T18:00:00Z","seen":"2026-09-29T19:02:26Z","lang":"en","source":{"id":"aol.com","name":"aol.com","domain":"aol.com","outlet":{"wikidata":"Q27585","name":"AOL","type":"website","country":"US","designations":["business","company","enterprise","media company","online service provider","search engine","web portal"]}},"via":"gdelt-gkg-english","topics":["economy","business","health","politics"],"authors":["AOL"],"entities":[{"id":"Q2984214","name":"Eli Lilly","type":"org"}],"story":"st_4beqmtf4juhxvtlumsia","category":"economy-business","category_p":0.88,"sentiment":"positive","tone":0.37,"political":0.01},{"id":"n_c5ce6rbcgoctxju4r5bq","seq":720959,"kind":"article","title":"Eli Lilly diz que Zepbound supera versão de alta dose do Wegovy em perda de peso","title_en":"Eli Lilly says Zepbound surpasses high-dose version of Wegovy in weight loss","url":"https://valor.globo.com/empresas/noticia/2026/09/29/eli-lilly-diz-que-zepbound-supera-verso-de-alta-dose-do-wegovy-em-perda-de-peso.ghtml","summary":"A Eli Lilly informou que doses específicas da sua “caneta emagrecedora”, o Zepbound, proporcionaram uma redução de peso superior à obtida com a versão de alta dosagem do concorrente Wegovy, desenvolvido pela rival Novo, segundo uma análise recente. Matéria exclusiva para assinantes. Para ter acesso completo, acesse o link da matéria e faça o seu cadastro.","published":"2026-09-29T15:53:05Z","seen":"2026-09-29T16:48:37Z","lang":"pt","country":"BR","source":{"id":"kite-pox-globo-com-4344ca","name":"pox.globo.com","domain":"pox.globo.com"},"via":"kite-pox-globo-com-4344ca","topics":["valor"],"entities":[{"id":"Q2984214","name":"Eli Lilly","type":"org"},{"id":"Q133859283","name":"Wegovy","type":"other"}],"image":"https://s2-valor.glbimg.com/mQYY0W_IMZr7QZTCjUPufzojVw4=/i.s3.glbimg.com/v1/AUTH_63b422c2caee4269b8b34177e8876b93/internal_photos/bs/2025/C/j/Zrwg9BSLmI7XjIkpLCNw/weighing-scale-7053082-1280.jpg","story":"st_c5ce6rbcgoctxju4r5bq","category":"health","category_p":0.25,"sentiment":"positive","tone":0.28,"political":0.03},{"id":"n_a4xi5ruasetu5r62ptea","seq":612129,"kind":"article","title":"Eli Lilly: Vårt piller är bättre än Novos","title_en":"Eli Lilly: Our pill is better than Novos","url":"https://www.di.se/live/eli-lilly-vart-piller-ar-battre-an-novos","summary":"Amerikanska Eli Lilly har under diabeteskongressen EASD (European Association för the Study of Diabetes) presenterat data från en indirekt jämförelse mellan bolagets orala fetmaläkemedel Fundayo, som visade en signifikant större viktnedgång och bättre blodsockerkontroll än det konkurrerande läkemedlet Wegovy-pillret (oralt semaglutid) från danska Novo.","published":"2026-09-29T07:44:52Z","seen":"2026-09-29T08:12:22Z","lang":"sv","country":"SE","source":{"id":"kite-di-se-755352","name":"di.se","domain":"di.se","outlet":{"wikidata":"Q734293","name":"Dagens Industri","type":"newspaper","designations":["newspaper"]}},"via":"kite-di-se-755352","authors":["Nyhetsbyrån Direkt"],"entities":[{"id":"Q2984214","name":"Eli Lilly","type":"org"}],"image":"https://static.bonniernews.se/ba/4cb09c52-9d36-4841-acd0-73b32a1a9078.png?width=600","story":"st_a4xi5ruasetu5r62ptea","category":"health","category_p":0.43,"sentiment":"positive","tone":0.53,"political":0.09},{"id":"n_n7i5nbobmtrzw7erotba","seq":535580,"kind":"article","title":"Can Roche's Latest Obesity Drug Results Help it Challenge Eli Lilly and Novo Nordisk?","url":"https://www.insidermonkey.com/news/can-roches-latest-obesity-drug-results-help-it-challenge-eli-lilly-and-novo-nordisk-1846125","published":"2026-09-28T22:39:17Z","seen":"2026-09-28T22:39:17Z","lang":"en","source":{"id":"insidermonkey.com","name":"insidermonkey.com","domain":"insidermonkey.com"},"via":"gdelt-gkg-english","topics":["business","economy","health"],"authors":["Noor Ul Ain Rehman"],"entities":[{"id":"Q2160232","name":"Roche","type":"org"},{"id":"Q2984214","name":"Eli Lilly","type":"org"},{"id":"Q818846","name":"Novo","type":"org"}],"story":"st_n7i5nbobmtrzw7erotba","category":"health","category_p":0.49,"category2":"economy-business","sentiment":"neutral","tone":-0.01,"political":0.04},{"id":"n_k7ausouswfgnsvbhuerq","seq":439075,"kind":"article","title":"Could This Mid-Cap GLP-1 Stock Be a Better Buy Than Eli Lilly?","url":"https://www.aol.com/articles/could-mid-cap-glp-1-132141000.html","published":"2026-09-28T13:21:00Z","seen":"2026-09-28T13:36:37Z","lang":"en","source":{"id":"aol.com","name":"aol.com","domain":"aol.com","outlet":{"wikidata":"Q27585","name":"AOL","type":"website","country":"US","designations":["business","company","enterprise","media company","online service provider","search engine","web portal"]}},"via":"gdelt-gkg-english","authors":["AOL"],"entities":[{"id":"Q2984214","name":"Eli Lilly","type":"org"}],"story":"st_k7ausouswfgnsvbhuerq","category":"economy-business","category_p":0.8,"sentiment":"neutral","tone":0.39,"political":0.01},{"id":"n_pihmzpdegb2tyj4owveq","seq":424314,"kind":"article","title":"Eli Lilly Just Announced Game-Changing News","url":"https://www.fool.com/investing/2026/09/28/eli-lilly-just-announced-game-changing-news?source=iedfolrf0000001","published":"2026-09-28T08:03:00Z","seen":"2026-09-28T12:23:21Z","lang":"en","source":{"id":"fool.com","name":"fool.com","domain":"fool.com","outlet":{"wikidata":"Q7752442","name":"The Motley Fool","type":"other","country":"US","designations":["dot-com company"]}},"via":"gdelt-gkg-english","topics":["economy","health","business"],"authors":["Adria Cimino"],"entities":[{"id":"Q2984214","name":"Eli Lilly","type":"org"}],"story":"st_qbq2lumivrsfofjdjiaa","category":"sport","category_p":0.82,"sentiment":"positive","tone":0.21,"political":0.04},{"id":"n_v3ozqmazfbgyleuiucha","seq":529370,"kind":"article","title":"Eli Lilly supports Kenosha-area food pantries","url":"https://journaltimes.com/news/community/article_67b81fd4-186d-5e2a-bd55-767d79228003.html","published":"2026-09-27T20:00:00Z","seen":"2026-09-28T21:51:35Z","lang":"en","source":{"id":"journaltimes.com","name":"journaltimes.com","domain":"journaltimes.com","outlet":{"wikidata":"Q56119164","name":"Journal Times","type":"newspaper","country":"US","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["food","security","economy","health"],"authors":["Kenosha Area Business Alliance"],"entities":[{"id":"Q2984214","name":"Eli Lilly","type":"org"}],"story":"st_v3ozqmazfbgyleuiucha","category":"arts-culture-entertainment","category_p":0.21,"sentiment":"positive","tone":0.7,"political":0.16},{"id":"n_fz2r5xo36goo5ctmi7xa","seq":246859,"kind":"article","title":"Abnehmspritzen: Eli Lilly sponsert Vogue-World-Show und löst Kritik aus","title_en":"Weight loss injections: Eli Lilly sponsors Vogue-World-Show and triggers criticism","url":"https://www.spiegel.de/panorama/abnehmspritzen-eli-lilly-sponsert-vogue-world-show-und-loest-kritik-aus-a-bbac5474-bab2-40f1-84cb-bb0264e96757","summary":"Der Pharmakonzern Eli Lilly sponsert ein Modeevent in Mailand und ruft damit Kritiker auf den Plan. Sie warnen vor einem neuen Schlankheitswahn und den Gewinninteressen der Medikamentenhersteller.","published":"2026-09-27T12:14:00Z","seen":"2026-09-27T12:53:26Z","lang":"de","country":"DE","source":{"id":"kite-spiegel-de-7e6cdb","name":"spiegel.de","domain":"spiegel.de","outlet":{"wikidata":"Q278151","name":"Der Spiegel","type":"newspaper","country":"DE","designations":["newspaper","online newspaper"]}},"via":"kite-spiegel-de-7e6cdb","topics":["panorama"],"entities":[{"id":"Q2984214","name":"Eli Lilly","type":"org"}],"image":"https://cdn.prod.www.spiegel.de/images/604a9ca0-89e7-4ff8-9e71-b6ef1bc1d959_w520_r2.08_fpx66.67_fpy50.jpg","story":"st_fz2r5xo36goo5ctmi7xa","category":"arts-culture-entertainment","category_p":0.31,"sentiment":"negative","tone":-0.36,"political":0.13}]}